Ratings PT Medco Energi Internasional Tbk

Equities

MEDC

ID1000053705

End-of-day quote INDONESIA S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1,350 ^IDR	-0.74%		-8.78%	+16.88%

Apr. 02	PT Medco Energi Internasional Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Medco Energi Internasional Tbk completed the acquisition of 20% stake in Block 60 producing and Block 48 exploration licenses in Oman from Oq Exploration And Production.	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Its low valuation, with P/E ratio at 92213.11 and 96982.76 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Sales forecast by analysts have been recently revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
One of the major weak points of the company is its financial situation.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Oil & Gas Exploration and Production

	1st Jan change	Capi.	ESG Refinitiv
PT MEDCO ENERGI INTERNASIONAL TBK	+16.88%	2.08B	-
CHEVRON CORPORATION	+6.97%	297B	A-
CONOCOPHILLIPS	+7.00%	147B	C
CNOOC LIMITED	+56.15%	128B	B+
CANADIAN NATURAL RESOURCES LIMITED	+19.00%	81.38B	B
EOG RESOURCES, INC.	+7.14%	76B	B-
PIONEER NATURAL RESOURCES COMPANY	+17.68%	62.92B	B-
OCCIDENTAL PETROLEUM CORPORATION	+7.20%	58.63B	C+
HESS CORPORATION	+7.58%	48.36B	A-
DIAMONDBACK ENERGY, INC.	+25.04%	35.87B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes